Gyrodyne LLC
GYRO · NASDAQ
$4.50+$0.08 (+1.81%)TodayMarket closed ·
Prev close $4.42
Key indicators
GYRO profitability and balance sheet ratios
EPS -$0.0475 in Jun 2015, against -$0.036 a year earlier.
| Period | EPS |
|---|---|
| Sep 2013 | $32.85 |
| Dec 2013 | -$0.8884 |
| Mar 2014 | $0.0082 |
| Jun 2014 | -$0.036 |
| Sep 2014 | -$0.0134 |
| Dec 2014 | $0.1411 |
| Mar 2015 | -$0.0424 |
| Jun 2015 | -$0.0475 |
Income statement
Revenue and profit by reporting period
Revenue
Net income
| Line item | Q1 FY22 | Q4 FY22 | Q1 FY23 |
|---|---|---|---|
| Revenue | $0.0M | $0.0M | $0.0M |
| Gross profit | $0.0M | $0.0M | $0.0M |
| Operating income | $0.0M | $0.0M | $0.0M |
| Net income | $0.0M | $0.0M | $0.0M |
| Diluted EPS | $0.00 | $0.00 | $0.00 |
Balance sheet
What the company owns and owes at period end
Total assets
Total liabilities
| Line item | Dec 2024 | Mar 2025 | Jun 2025 |
|---|---|---|---|
| Total assets | $56.7M | $56.0M | $61.0M |
| Total liabilities | $26.1M | $25.0M | $28.0M |
| Shareholder equity | $30.6M | $31.0M | $33.0M |
| Cash and short-term investments | $5.9M | $5.8M | $5.5M |
| Total debt | $11.2M | $11.0M | $11.0M |
Cash flow
Cash in and out from operations, investing and financing
| Line item | Q3 FY22 | Q4 FY22 | Q2 FY23 |
|---|---|---|---|
| Operating cash flow | $0.0M | $0.0M | $0.0M |
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.